PFE - Pfizer Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue53,647,00052,546,00052,824,00048,851,000
Cost of Revenue11,128,00010,578,00011,918,0009,361,000
Gross Profit42,519,00041,968,00040,906,00039,490,000
Operating Expenses
Research Development7,959,0007,645,0007,858,0007,646,000
Selling General and Administrative13,943,00014,606,00014,894,00014,325,000
Non Recurring----
Others-1,002,000-1,002,000-1,002,000-1,002,000
Total Operating Expenses37,923,00037,587,00038,726,00035,060,000
Operating Income or Loss15,724,00014,959,00014,098,00013,791,000
Income from Continuing Operations
Total Other Income/Expenses Net-3,839,000-2,655,000-5,745,000-4,826,000
Earnings Before Interest and Taxes15,724,00014,959,00014,098,00013,791,000
Interest Expense-1,316,000-1,270,000-1,186,000-1,199,000
Income Before Tax11,885,00012,304,0008,353,0008,965,000
Income Tax Expense706,000-9,049,0001,123,0001,990,000
Minority Interest351,000348,000296,000278,000
Net Income From Continuing Ops11,179,00021,353,0007,230,0006,975,000
Non-recurring Events
Discontinued Operations10,0002,00016,00011,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income11,153,00021,308,0007,215,0006,960,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares11,152,00021,307,0007,214,0006,959,000